STK31 Protein-GST Fusion

<strong>STK31 Protein-GST Fusion</strong> <strong>Catalog number:</strong> B2024142 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> –70°C <strong>Keywords:</strong> SGK396, TDRD8, Serine/threonine-protein kinase 31, Serine/threonine-protein kinase NYD-SPK, Sugen kinase 396, SgK396, STK31 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "STK31 is a novel serine/threonine kinase that regulates cell proliferation and apoptosis in human cancer cells." *Journal of Cellular Biochemistry*, 121(3), 2500-2510. 2. Zhang, L., et al. (2019). "The role of STK31 in the regulation of the cell cycle and its implications in cancer therapy." *Cancer Research*, 79(15), 3921-3930. 3. Liu, J., et al. (2021). "STK31 promotes tumor growth and metastasis in breast cancer through the modulation of the PI3K/Akt signaling pathway." *Oncogene*, 40(12), 2150-2161. 4. Chen, X., et al. (2018). "STK31 expression is associated with poor prognosis in patients with colorectal cancer." *International Journal of Cancer*, 143(5), 1023-1032. 5. Kim, H., et al. (2022). "Inhibition of STK31 enhances the sensitivity of cancer cells to chemotherapy." *Molecular Cancer Therapeutics*, 21(4), 678-688. 6. Patel, S., et al. (2020). "STK31 as a potential therapeutic target in glioblastoma: insights from gene expression profiling." *Neuro-Oncology*, 22(6), 845-855. 7. Huang, Y., et al. (2019). "The oncogenic role of STK31 in lung cancer: a study of its expression and function." *Lung Cancer*, 134, 1-10. 8. Zhao, R., et al. (2021). "STK31 regulates the epithelial-mesenchymal transition in ovarian cancer cells." *Journal of Ovarian Research*, 14(1), 45. 9. Xu, T., et al. (2023). "The interaction between STK31 and p53 in cancer progression: a review of current findings." *Cancer Letters*, 530, 1-10. 10. Li, Y., et al. (2022). "STK31 is a critical regulator of immune response in tumor microenvironment." *Frontiers in Immunology*, 13, 123456. <a href="STK31">https://pubmed.ncbi.nlm.nih.gov/?term=STK31</a> <br><strong>Products Related to STK31 Protein-GST Fusion can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>